ArticleMedicine2026
The risk factors associated with pulmonary hypertension in patients with left heart diseases.
Article in Medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Pulmonary hypertension (PH) is an important reason for morbidity and mortality in patients with left heart disease (LHD). LHD is one the most common cause of PH in the elderly. Few studies have reported risk factors in patients with PH accompanied with LHD. To identify associated risk factors with PH in patients with LHD in elderly. A total of 411 aged male patients (>60 years) with LHDs were enrolled in this trail. Pulmonary artery systolic pressure (PASP), heart chamber diameters, and left ventricular functions were evaluated by transthoracic echocardiography. Patients were classified as PH group (n = 211) and non-PH group (n = 200) according to their PASP. Clinical history was collected from medical recordings. Independent associated factors for PH were identified by Logistic regression analysis. Compared with non-PHs, PH patients were more likely to have atrial fibrillation (AF; 21% vs 9.4%, P < .01), left atrial enlargement (39.25 ± 4.96 mm vs 36.94 ± 3.16 mm, P < .01), and reduced left ventricular ejection fraction (LVEF; 58.97 ± 6.51% vs 61.15 ± 4.72%, P < .01). Multivariate logistic regression analysis showed that AF, larger left atrial diameter, lower LVEF was independently associated with the presence of PH in patients with LHDs. In patients with PH, the PASP and left atrial diameter were all related to the number of co-morbidities (P < .05). AF, left atrial enlargement, and decreased LVEF are associated with the presence of PH in patients with LHDs. Well control of comorbidities and underlying heart diseases, prevention or treatment of AF may play key roles in the management of PH in patients with LHDs.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.